Survival motor neuron 2 gene promoter (SMN2 gene promoter)

The SMN2 gene promoter is the region of DNA that controls the transcription of the SMN2 gene, which encodes the Survival motor neuron protein, a critical factor in motor neuron maintenance[4][7]. It contains multiple regulatory elements, including CpG islands modulated by DNA methylation, and sequence motifs for binding transcription factors such as MeCP2[2][3]. Differential methylation and binding of repressors to this promoter region result in reduced expression of the full-length SMN2 transcript, contributing to the pathogenesis of spinal muscular atrophy (SMA) when SMN1 is absent[1][2][5][6]. Therapeutic approaches now target this promoter to increase SMN2 expression independently of splicing, using drugs such as antisense oligonucleotides or gene therapy vectors[1][5]. The promoter is structurally similar to that of the SMN1 gene but can be regulated in a neuron-specific manner by enhancer and silencer elements[5]. Its epigenetic and transcriptional status is under investigation as a biomarker and drug target for SMA.

Other names

SMN2 promoterSMN2 gene regulatory region

Demethylation of promoter CpGs to increase transcription; Blocking transcriptional repressors such as MeCP2 from binding; Enhancing promoter activity via gene therapy or antisense approaches to increase full-length SMN2 mRNA expression